Bulletin
Investor Alert

BioNTech SE ADR

NAS: BNTX

GO
/marketstate/country/us

After Hours

/zigman2/quotes/214419716/composite

$

66.50

Change

-0.19 -0.28%

Volume

Volume 9,872

Sep 25, 2020, 6:01 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/214419716/composite

Today's close

$ 62.83

$ 66.69

Change

+3.86 +6.14%

Day low

Day high

$61.27

$66.87

Open
Open: 61.27

52 week low

52 week high

$12.53

$105.00

Open

Market cap

$14.96B

Average volume

3.60M

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-0.95

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/bntx

MarketWatch News on BNTX

  1. Why Covid-19 Vaccine Prices May Be Unexpectedly Low

    1:30 p.m. Today

    - Bill Alpert

  2. Novavax Starts a Phase 3 Trial of Its Covid-19 Vaccine

    9:07 a.m. Today

    - Bill Alpert

  3. Moderna Shares the Latest on its Vaccine Trial

    5:23 p.m. Sept. 17, 2020

    - Bill Alpert

  4. Loading more headlines...
/news/nonmarketwatch/company/us/bntx

Other News on BNTX

  1. Covid-19 Vaccines: What’s Coming and When?

    3:13 p.m. Today

    - Ana Rivas

  2. Vaccine news roundup - Cuomo sets up panel for separate NY review

    3:54 a.m. Today

    - Seeking Alpha

  3. White House may overrule tightening of FDA vaccine rules

    4:03 a.m. Sept. 24, 2020

    - Seeking Alpha

  4. The Zacks Analyst Blog Highlights: NVAX, MRNA, VIR and BNTX

    12:41 p.m. Sept. 23, 2020

    - Zacks.com

  5. U.K. to host first human challenge studies for COVID-19 vaccines

    10:08 a.m. Sept. 23, 2020

    - Seeking Alpha

  6. UK to host first human challenge studies for COVID-19 vaccines

    10:08 a.m. Sept. 23, 2020

    - Seeking Alpha

  7. InSysBio partners with Genmab in solid tumours

    9:58 a.m. Sept. 23, 2020

    - Seeking Alpha

  8. Berenberg Bank Remains a Buy on BioNTech SE (BNTX)

    5:08 a.m. Sept. 23, 2020

    - SmarterAnalyst

  9. Keep An Eye On Novavax, But Keep Your Money In Your Pocket

    1:19 p.m. Sept. 22, 2020

    - InvestorPlace.com

  10. Pfizer Shares May Catch Momentum Soon From Vaccine Work

    1:15 p.m. Sept. 22, 2020

    - InvestorPlace.com

  11. Pfizer Is Your Best Bet at a Covid-19 Vaccine Play

    12:56 p.m. Sept. 22, 2020

    - InvestorPlace.com

  12. 4 Biotechs That Have More Than Doubled Thanks to Coronavirus

    10:01 a.m. Sept. 22, 2020

    - Zacks.com

  13. Moderna Stock Looks Like a Winner as the Covid-19 Vaccine Race Loosens

    8:10 a.m. Sept. 22, 2020

    - InvestorPlace.com

  14. Global vaccine plan gains momentum, U.S. not on board

    5:43 a.m. Sept. 22, 2020

    - Seeking Alpha

  15. The Vaccine Protocols

    7:59 p.m. Sept. 21, 2020

    - Seeking Alpha

  16. Loading more headlines...
/news/pressrelease/company/us/bntx

Press Releases on BNTX

  1. Vaccine Updates

    10:12 a.m. Sept. 24, 2020

    - IAM Newswire

  2. Pfizer and BioNTech Propose Expansion of Pivotal COVID-19 Vaccine Trial

    10:45 a.m. Sept. 12, 2020

    - BusinessWire - BZX

  3. Biopharma Leaders Unite to Stand With Science

    6:31 a.m. Sept. 8, 2020

    - BusinessWire - BZX

  4. Biopharma Leaders Unite to Stand with Science

    6:30 a.m. Sept. 8, 2020

    - GlobeNewswire

  5. Biopharma Leaders Unite To Stand With Science

    6:30 a.m. Sept. 8, 2020

    - BusinessWire - BZX

  6. Biopharma Leaders Unite to Stand with Science

    6:30 a.m. Sept. 8, 2020

    - BusinessWire - BZX

  7. Biopharma Leaders Unite to Stand with Science

    6:30 a.m. Sept. 8, 2020

    - GlobeNewswire

  8. Biopharma Leaders Unite to Stand with Science

    6:30 a.m. Sept. 8, 2020

    - Globe Newswire

  9. Loading more headlines...

Rates »

Link to MarketWatch's Slice.